StonvexLoading…
StonvexStonvexStonvexCore line items from JMIA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $188.93M | $167.49M | $186.40M | $203.30M |
Operating Income | $-63.21M | $-66.00M | $-73.31M | $-201.80M |
Net Income | $-61.54M | $-99.11M | $-104.18M | $-238.27M |
EPS (Diluted) | $-0.25 | $-0.45 | $-0.52 | $-1.19 |
Total Assets | $133.55M | $192.07M | $189.94M | $330.22M |
Total Liabilities | $107.82M | $105.79M | $121.22M | $155.97M |
Cash & Equivalents | $76.67M | $55.36M | $35.48M | $71.58M |
Free Cash Flow OCF − CapEx | $-52.59M | $-60.88M | $-75.23M | $-251.32M |
Shares Outstanding | Not available | Not available | Not available | Not available |